Polycystic Liver Disease
Polycystic liver diseases, a group of genetic cholangiopathies, are characterized by progressive dilatation of biliary epithelial cysts. The dominant pathology of the adult polycystic kidney (ADPKD) is caused by mutations in the genes that code for ciliary proteins, polycystins. Polycystins function as mechanoreceptors but are also involved in cell differentiation and epithelial morphogenesis. Our recent studies show that angiogenic growth factors, in particular VEGF and Angiopoietin-1, are overexpressed in ADPKD epithelial bile cells (cholangiocytes) and may play a role in the pathogenesis of liver disease. Starting from these observations, the hypothesis of this project is that the autocrine and paracrine angiogenetic signals produced by the biliary epithelium are the key responsible for the growth of liver cysts and the progression of the disease in ADPKD.
These studies will allow us to understand the basic mechanisms responsible for the pathogenesis of polycystic liver disease and to device pharmacological strategies useful as disease therapy. The results will also have a more general relevance to better understand the fundamental mechanisms that regulate angiogenesis in liver diseases.
Selected Publications:
- Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.Spirli C, Mariotti V, Villani A, Fabris L, Fiorotto R, Strazzabosco M. J Hepatol. 2017 Mar; 2016 Nov 5. PMID: 27826057.
- Vascular biology of the biliary epithelium.Morell CM, Fabris L, Strazzabosco M. J Gastroenterol Hepatol. 2013 Aug. PMID: 23855292.
- Vascular endothelial growth factors in progenitor cells mediated liver repair.Spirli C, Strazzabosco M. Hepatobiliary Surg Nutr. 2013 Apr. PMID: 24570918.
- Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.Spirli C, Morell CM, Locatelli L, Okolicsanyi S, Ferrero C, Kim AK, Fabris L, Fiorotto R, Strazzabosco M. Hepatology. 2012 Dec; 2012 Aug 27. PMID: 22653837.
- Altered store operated calcium entry increases cyclic 3',5'-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes.Spirli C, Locatelli L, Fiorotto R, Morell CM, Fabris L, Pozzan T, Strazzabosco M. Hepatology. 2012 Mar. PMID: 21987453.
- Polycystic liver diseases: congenital disorders of cholangiocyte signaling.Strazzabosco M, Somlo S. Gastroenterology. 2011 Jun; 2011 Apr 22. PMID: 21515270.
- Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M. Hepatology. 2010 May. PMID: 20131403.
- ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M. Gastroenterology. 2010 Jan; 2009 Sep 18. PMID: 19766642.
- Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.Alvaro D, Onori P, Alpini G, Franchitto A, Jefferson DM, Torrice A, Cardinale V, Stefanelli F, Mancino MG, Strazzabosco M, Angelico M, Attili A, Gaudio E. Am J Pathol. 2008 Feb; 2008 Jan 17. PMID: 18202196.
- Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development.Fabris L, Cadamuro M, Libbrecht L, Raynaud P, Spirlì C, Fiorotto R, Okolicsanyi L, Lemaigre F, Strazzabosco M, Roskams T. Hepatology. 2008 Feb. PMID: 18157837.
- Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.Fabris L, Cadamuro M, Fiorotto R, Roskams T, Spirlì C, Melero S, Sonzogni A, Joplin RE, Okolicsanyi L, Strazzabosco M. Hepatology. 2006 May. PMID: 16628643.